Status:
COMPLETED
Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
Lead Sponsor:
Yuhan Corporation
Conditions:
Hyperlipidemia
Hypertension
Eligibility:
All Genders
19+ years
Phase:
PHASE3
Brief Summary
To evaluate efficacy and safety of YH16410 versus rosuvastatin and telmisartan monotherapies in patients with hypertension and hyperlipidemia
Eligibility Criteria
Inclusion
- Signed Informed Consent
- Men and women ≥ 19 years of age
- Subject who has one of 3 conditions classified by Cardiovascular Risk Factors, 10-Year Risk, Blood Pressure, LDL-C, TG, Coronary Artery Disease and Equivalent
Exclusion
- Females who are pregnant, breastfeeding, or of childbearing potential, unwilling to practice adequate contraception throughout the study.
- Other exclusions applied
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01914432
Start Date
November 1 2013
End Date
June 1 2014
Last Update
July 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea